Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy.

Although this difference did not reach statistical significance because of the small number of patients in each group ( P = 0.3492), none of the long‐term recurrent GBM survivors displayed a density of greater than ten PD‐L1 expressing cells mm −2 .

also in 111,027 other papers